Factors for the development of anemia in patients with newly introduced olaparib: A retrospective case-control study

Anemia is the most common dose-limiting toxicity of olaparib. However, few studies have analyzed the clinical features of olaparib-induced anemia. This study investigated the clinical features of olaparib-induced anemia. Additionally, the role of folate or vitamin B(12) in olaparib-induced anemia wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Chihiro, Shiraishi, Hirai, Toshinori, Kaneda, Michiko, Okamoto, Akiharu, Kato, Hideo, Tanaka, Kayo, Kondo, Eiji, Ikeda, Tomoaki, Iwamoto, Takuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Research Article: Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378826/
https://www.ncbi.nlm.nih.gov/pubmed/37505180
http://dx.doi.org/10.1097/MD.0000000000034123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378826/
https://www.ncbi.nlm.nih.gov/pubmed/37505180
http://dx.doi.org/10.1097/MD.0000000000034123

Ejemplares similares